AscellaHealth
Specialty Pharmacy and Healthcare Services Organization
AscellaHealth, headquartered in Berwyn, Pennsylvania, with a presence across the United States and Europe, stands as a beacon in the Specialty Pharmacy and Healthcare services sector. The company has carved a niche in offering specialized, technology-driven pharmaceutical and medical management services, catering specifically to the needs of payers, providers, life sciences companies, and patients. At its core, the company utilizes proprietary technology to foster innovative programs and services that aim to enhance health outcomes and improve the quality of life for patients dealing with complex, chronic conditions or rare diseases necessitating specialty medications, including gene and cell therapies.
Under the leadership of CEO and Co-founder Dea Belazi, AscellaHealth has emerged as a global powerhouse in Healthcare & Specialty Pharmacy (S.P.) solutions. Employing over 200 professionals globally, the organization is dedicated to providing innovative, customized solutions that enhance medication accessibility and improve patient outcomes, particularly for those with specialty conditions or rare diseases. With his rich experience as a business executive and clinical acumen as a Registered Pharmacist, Belazi has skillfully crafted AscellaHealth's extensive service offerings to meet the complex demands of pharmaceutical manufacturers and other industry stakeholders.
Bill Oldham, serving as Chairman, President, and Co-founder, has effectively integrated his extensive fintech expertise into the pharmacy benefit management (PBM) sector, positioning AscellaHealth as a leader in the Specialty Pharmacy space. His strategic initiatives have propelled the company to a 1556% increase in revenue over four years through organic growth and acquisitions. Oldham's accomplishments have earned him recognition as the Philadelphia Business Journal's 2022 CFO of the Year and as a Philadelphia Titan 100 in both 2023 and 2024.
About AscellaHealth: Better Data for Better Health
AscellaHealth combines clinical, financial, and technological resources to streamline access to specialty medications, thereby improving clinical outcomes and enriching the therapy experience for patients with chronic or complex conditions requiring specialty pharmaceuticals, cell, and gene therapies. The organization's comprehensive services span Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, Proprietary Specialty Pharmacy and Infusion Network, Customized Clinical Programs, Technology-based Patient Engagement, Medical and Pharmacy Benefit Management, Drug Rebate Programs, and Real-Time Prescription Data and Analytics, all facilitated through its proprietary technology platform.
AscellaHealth's Solutions
Life Sciences
AscellaHealth is the exclusive launch partner for life sciences companies navigating the commercialization of treatments for complex, chronic conditions. It offers a comprehensive array of services that assist these companies from clinical trials through to patient product transitions, including pre-commercialization resources, distribution and fulfillment, patient support and HUB services, and comprehensive data and analysis.
Payers & Health Plans
AscellaHealth delivers a broad suite of services that enhance patient outcomes and manage costs effectively for captives, self-insured companies, at-risk providers, PBMs, and regional health plans. These services include specialty and medical cost management, formulary and network design, custom clinical programs, and comprehensive data analysis.
AscellaHealth's Innovation Is Widely Recognized
AscellaHealth has earned a reputation as a leader in the global specialty pharmacy and healthcare services industry. It is celebrated for its innovative solutions and has received multiple awards and accolades, including the 2024 Top 10 Pharma & Life Science Solutions Providers and Health Tech Outlook's 2024 Top Pharmacy Management Solutions Provider.
About Dea Belazi
Dea Belazi, co-founder of AscellaHealth, has guided the company to significant industry acclaim, securing numerous prestigious awards such as The Financial Times Fastest Growing Company and Deloitte Fast 500. Notable honors, including EY Entrepreneur of The Year® National Finalist and Titan 100, mark his role in the Philadelphia business community. Belazi holds a PharmD from the University of Rhode Island, a Master of Public Health from Johns Hopkins University, and completed a post-doctoral health outcomes research fellowship at Thomas Jefferson University.
About Bill Oldham
Bill Oldham's nearly three decades of entrepreneurial, investment, and consultancy experience across health, technology, financial, and energy sectors have shaped AscellaHealth's strategic growth and innovation. His fintech expertise has significantly influenced the PBM industry, contributing to the development of two $100-million companies and managing global operations. Oldham's career began on Wall Street and has included leadership roles that utilized technology to transform sales and service delivery internationally. He holds an MBA from Manchester Business School focused on entrepreneurship and venture finance and a certification in Blockchain Technologies from MIT Sloan School of Management.